All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ2187 | Anti-SERBP1 (CBXS-5768) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-5768 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2188 | Anti-SERBP1 (CBXS-4079) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Dog, Mouse | CBXS-4079 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2189 | Anti-SERBP1 (CBXS-4429) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4429 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2190 | Anti-SERBP1 (CBXS-5081) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Dog, Human, Monkey | CBXS-5081 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2191 | Anti-SERBP1 (CBXS-2799) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2799 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5611 | Anti-SERBP1 (CBXS-5768) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-5768 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5612 | Anti-SERBP1 (CBXS-4079) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Dog, Mouse | CBXS-4079 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5613 | Anti-SERBP1 (CBXS-4429) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4429 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5614 | Anti-SERBP1 (CBXS-5081) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Dog, Human, Monkey | CBXS-5081 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5615 | Anti-SERBP1 (CBXS-2799) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2799 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION